Evidence map›Paper›PMID 41005843›Full record

ArticleJACC. Case reports2025

Cardiogenic Shock Patient Found to Have Cardiac Amyloidosis and Concurrent Multiple Myeloma.

Andy Jiang, Mannat Dhillon, Rajat Sharma, Paul Boucher, Yinong Wang, Nowell Fine, Omid Kiamanesh

Abstract readCase Reports
In one paragraph

Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Andy JiangDepartment of Cardiac Sciences, The University of Calgary, Calgary, Alberta, Canada.
Mannat DhillonDepartment of Cardiac Sciences, The University of Calgary, Calgary, Alberta, Canada.
Rajat SharmaDepartment of Cardiac Sciences, The University of Calgary, Calgary, Alberta, Canada.
Paul BoucherDepartment of Cardiac Sciences, The University of Calgary, Calgary, Alberta, Canada; Department of Critical Care Medicine, The University of Calgary, Calgary, Alberta, Canada.
Yinong WangDepartment of Pathology and Laboratory Medicine, The University of Calgary, Calgary, Alberta, Canada.
Nowell FineDepartment of Cardiac Sciences, The University of Calgary, Calgary, Alberta, Canada.
Omid KiamaneshDepartment of Cardiac Sciences, The University of Calgary, Calgary, Alberta, Canada. Electronic address: omid.kiamanesh@ucalgary.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiac amyloidosis is an under-recognized cause of heart failure. CASE SUMMARY: A 61-year-old man presented with acute decompensated heart failure and cardiogenic shock requiring peripheral venoarterial extracorporeal membrane oxygenation support. Endomyocardial biopsy revealed a diagnosis of light-chain cardiac amyloidosis. Work-up for incidentally noted hypercalcemia also revealed a rare diagnosis of concurrent multiple myeloma. Unfortunately, the patient clinically deteriorated with limited treatment options and ultimately died in hospital. DISCUSSION: We discuss this case in relation to the complexities of recognizing and making a diagnosis of cardiac amyloidosis as well as the atypical presentation with cardiogenic shock and concurrent multiple myeloma. TAKE-HOME MESSAGES: A broad differential diagnosis is required in patients with heart failure and worsening cardiogenic shock, including under-recognized etiologies such as cardiac amyloidosis. Though rare, cardiac amyloidosis can co-occur with multiple myeloma, and making the diagnosis early is important to inform available treatment options.

Indexed as

cardiogenic shockcardiomyopathylight-chain amyloidosis

Identifiers

PMID41005843
PMCPMC12539476

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.